Patents by Inventor Pascal DeGrace

Pascal DeGrace has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1,4-di-(4-methylthiophenyl)-3-phtaloylazetidine-2-one and the derivatives thereof
    Patent number: 10457665
    Abstract: The present invention relates to a compound with formula (I) or a salt and/or a pharmaceutically acceptable solvate thereof, the method for preparing same as well as the uses thereof, in particular the therapeutic use thereof, mainly in the treatment of diseases associated with a hyperactivity of the endocannabinoid system.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: October 29, 2019
    Assignees: Universite De Nantes, Universite de Bourgogne, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Jean-Michel Robert, Stéphanie Troy-Fioramonti, Laurent Demizieux, Pascal DeGrace
  • 1,4-DI-(4-METHYLTHIOPHENYL)-3-PHTALOYLAZETIDINE-2-ONE AND THE DERIVATIVES THEREOF
    Publication number: 20180265498
    Abstract: The present invention relates to a compound with formula (I) or a salt and/or a pharmaceutically acceptable solvate thereof, the method for preparing same as well as the uses thereof, in particular the therapeutic use thereof, mainly in the treatment of diseases associated with a hyperactivity of the endocannabinoid system.
    Type: Application
    Filed: September 23, 2016
    Publication date: September 20, 2018
    Applicants: Universite De Nantes, Universite de Bourgogne, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Jean-Michel Robert, Stéphanie Troy-Fioramonti, Laurent Demizieux, Pascal DeGrace